Literature DB >> 6990758

Hypoglycemia as a manifestation of sepsis.

S I Miller, R J Wallace, D M Musher, E J Septimus, S Kohl, R E Baughn.   

Abstract

Hypoglycemia has rarely been described as a clinical sign of severe bacterial sepsis. We recently encountered nine patients in whom hypoglycemia (mean serum glucose of 22 mg/dl) was associated with overwhelming sepsis. Clinical disease in these patients included pneumonia and cellulitis; in three patients, no focus of infection was apparent. Altered mental status, metabolic acidosis, leukopenia, abnormal clotting studies and bacteremia were common features in these cases. In four patients, no cause for hypoglycemia other than sepsis was present. In five patients, another possible metabolic cause for hypoglycemia was present (alcoholism in four and chronic renal insufficiency in one) although none had been observed to be hypoglycemic on previous hospitalizations. Streptococcus pneumoniae (three cases) and Hemophilus influenzae, type b, (two cases) were the most common pathogens, and the over-all mortality was 67 per cent. The mechanism(s) for hypoglycemia with sepsis is not well defined. Depleted glycogen stores, impaired gluconeogenesis and increased peripheral glucose utilization may all be contributing factors. Incubation of bacteria in fresh blood at room temperature does not increase the normal rate of breakdown of glucose suggesting that the hypoglycemia occurs in vivo. Hypoglycemia is an important sign of overwhelming sepsis that may be more common than has previously been recognized.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6990758     DOI: 10.1016/0002-9343(80)90250-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

1.  Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway.

Authors:  Carl F Raetzsch; Natasha L Brooks; J McKee Alderman; Kelli S Moore; Peter A Hosick; Simon Klebanov; Shizuo Akira; James E Bear; Albert S Baldwin; Nigel Mackman; Terry P Combs
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

2.  Septic shock.

Authors:  M R Achong
Journal:  Can Fam Physician       Date:  1980-10       Impact factor: 3.275

3.  Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in mice.

Authors:  Senri Oguri; Katsutoshi Motegi; Yoichiro Iwakura; Yasuo Endo
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 4.  Refeeding syndrome : physiological background and practical management.

Authors:  Aminda De Silva; Jeremy M D Nightingale
Journal:  Frontline Gastroenterol       Date:  2019-12-30

5.  Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use.

Authors:  Andrew J Karter; E Margaret Warton; Kasia J Lipska; James D Ralston; Howard H Moffet; Geoffrey G Jackson; Elbert S Huang; Donald R Miller
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

6.  Biochemical alterations in the mouse induced by Pseudomonas aeruginosa and its slime glycolipoprotein.

Authors:  M Lynn; L Lotz
Journal:  Br J Exp Pathol       Date:  1984-04

7.  Hypoglycaemia and septicaemia.

Authors:  T D Walsh
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

8.  Mathematical modeling of energy consumption in the acute inflammatory response.

Authors:  Ivan Ramirez-Zuniga; Jonathan E Rubin; David Swigon; Gilles Clermont
Journal:  J Theor Biol       Date:  2018-08-25       Impact factor: 2.691

9.  Hypoglycemia, hormones and cytokines in fatal meningococcal septicemia.

Authors:  J A Romijn; M H Godfried; C Wortel; H P Sauerwein
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

Review 10.  The role of macrophage migration inhibitory factor on glucose metabolism and diabetes.

Authors:  C Toso; J A Emamaullee; S Merani; A M J Shapiro
Journal:  Diabetologia       Date:  2008-07-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.